Loading...
Loading...
BNGO| Name | Value |
|---|---|
| Revenues | 7.8M |
| Cost of Revenue | 5.2M |
| Gross Profit | 2.6M |
| Operating Expense | 22.9M |
| Operating I/L | -20.3M |
| Other Income/Expense | 4.1M |
| Interest Income | 0.5M |
| Pretax | -16.2M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -16.2M |
Bionano Genomics, Inc. provides genome analysis software solutions, including the Saphyr sample-to-result solution for structural variation analysis and the Saphyr instrument for single-molecule imaging. The company also offers consumables such as the Saphyr Chip and Bionano Prep Kits, as well as NxClinical for analysis and interpretation of genomic variants. Additionally, Bionano provides testing and laboratory services, such as chromosomal microarray testing for autism spectrum disorder and developmental delay, exome sequencing for childhood development disorders, genetic testing panels for seizures and infantile spasms, and pharmacogenomic testing for identifying genetic variants in 11 genes.
